Welcome to Central Library, SUST

Handbook of HER2-targeted agents in breast cancer (Record no. 45189)

MARC details
000 -LEADER
fixed length control field 03622nam a22006377a 4500
001 - CONTROL NUMBER
control field sulb-eb0023097
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20160413122334.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140528s2013 xxk| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781907673948
-- 978-1-907673-94-8
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-907673-94-8
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Alvarez, Ricardo H.
Relator term author.
245 10 - TITLE STATEMENT
Title Handbook of HER2-targeted agents in breast cancer
Medium [electronic resource] /
Statement of responsibility, etc. by Ricardo H Alvarez, Javier Cortés, Leticia De Mattos-Arruda, Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart, Stefania Zambelli, Dimitrios Zardavas.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Tarporley :
Name of producer, publisher, distributor, manufacturer Springer Healthcare Ltd. :
-- Imprint: Springer Healthcare,
Date of production, publication, distribution, manufacture, or copyright notice 2013.
300 ## - PHYSICAL DESCRIPTION
Extent XI, 96 p. 13 illus.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Introduction and background biology -- HER2 testing -- HER2-positive breast cancer: adjuvant and neoadjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer.
520 ## - SUMMARY, ETC.
Summary, etc. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year.  Of these cases, approximately  15–25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes.  However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer  provides oncologists, primary care physicians, trainees and other healthcare providers with a concise, accessible, and up-to-date survey of the field, including a review of our current understanding of the biology of the HER2 pathway and the rationale for targeting it in early-stage and advanced breast cancer, an overview of HER2-testing, and evidence-based discussions of available HER2-targeted regimens in the adjuvant and metastatic settings.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element General practice (Medicine).
Topical term or geographic name as entry element Internal medicine.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Primary care (Medicine).
Topical term or geographic name as entry element Pharmacotherapy.
Topical term or geographic name as entry element Medicine & Public Health.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Primary Care Medicine.
Topical term or geographic name as entry element General Practice / Family Medicine.
Topical term or geographic name as entry element Internal Medicine.
Topical term or geographic name as entry element Pharmacotherapy.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cortés, Javier.
Relator term author.
Personal name Mattos-Arruda, Leticia De.
Relator term author.
Personal name Falzon, Mary.
Relator term author.
Personal name Fasolo, Angelica.
Relator term author.
Personal name Gandy, Michael.
Relator term author.
Personal name Gianni, Luca.
Relator term author.
Personal name Harbeck, Nadia.
Relator term author.
Personal name Piccart, Martine.
Relator term author.
Personal name Zambelli, Stefania.
Relator term author.
Personal name Zardavas, Dimitrios.
Relator term author.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781907673931
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1007/978-1-907673-94-8">http://dx.doi.org/10.1007/978-1-907673-94-8</a>
912 ## -
-- ZDB-2-SME
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type

No items available.